Off-market insider buying at VentriPoint Diagnostics (VPT)

Off-market insider buying at VentriPoint Diagnostics (V:VPT)

Robert Hodgkinson, a Director, acquired 1,333,334 Common Shares on a direct ownership basis at a price of $0.075 through a private transaction on January 27th, 2021. The insider also acquired 1,333,334 Common Shares on an indirect ownership basis for registered holder Hodgkinson Equities Corporation. This represents a $200,000 investment into the company's shares and an account share holdings change of greater than 100%.

VentriPoint Diagnostics is in the Advanced Medical Equipment & Technology Sub Industry Group under the Healthcare Sector.

Ventripoint Diagnostics Ltd., formerly Luca Capital Inc., is a medical device company. The Company is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. By using images produced from existing medical imaging systems, the Ventripoint Medical System (VMS) generates accurate heart volumetric measurements and a three-dimensional (3D) model in a rapid and inexpensive manner. The Company's solution produces critical heart information by processing standard information received from existing medical imaging equipment with its methods incorporating Knowledge Based Reconstruction (KBR) algorithms and cardiac databases (catalogues). Its technology platform is applicable to all heart diseases. The Company has developed prototype analytical software package to be used with 4D echocardiograms (VMS-4DE) and one to be used with magnetic resonance imaging (MRI) images (VMS-CMR). It also focuses on developing VMS-Plus and the VMS-Nano.